AlphaYou
Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 20- 52-wk high
- $131.24
- 52-wk low
- $32.00
- Prev close
- $79.10
- Mkt cap
- $4.65B
- P/B
- 5.7x
- Profit margin
- +0.0%
Smart money
Earnings
Earnings landed in line with what analysts expected.
Financials
What it sold, what it cost, what was left.
Dec 2024Mar 2025Dec 2025Mar 2026
| USD | Dec 2024 | Mar 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $0 | $0 | $0 | $0 |
| What it spent | ||||
| Research and development | $5.0M | $11.4M | $18.2M | $20.9M |
| Sales and admin | $1.0M | $1.5M | $4.8M | $8.9M |
| Total operating expenses | $6.0M | $12.9M | $23.0M | $29.9M |
| What was left | ||||
| Operating profit | -$6.0M | -$12.9M | -$23.0M | -$29.9M |
| Interest on debt | $292.0K | — | $532.0K | — |
| Profit before tax | -$5.7M | -$12.4M | -$21.8M | -$27.2M |
| Net profit | -$5.7M | -$12.4M | -$21.8M | -$27.2M |
| EBITDA | -$5.4M | — | -$21.3M | -$27.2M |
Technicals
Price structure
No data yet
Technicals sync when verified market data is available. No sample data is shown.
News
What the news says
22 articles · 7 days
Coverage is mixed
Tone of tracked coverage
Veradermics (NYSE:MANE) CEO Reid Alexander Waldman Sells 67,500 Shares of Stock
Leans bullishAug 19Veradermics (NYSE:MANE) Insider Timothy August Durso Sells 43,500 Shares
NeutralAug 19Veradermics (MANE) CTO unloads tens of thousands of shares in preset trades
BearishAug 19
